295 related articles for article (PubMed ID: 32344275)
1. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).
Altschuler EL; Kast RE
Med Hypotheses; 2020 Aug; 141():109774. PubMed ID: 32344275
[No Abstract] [Full Text] [Related]
2. P-selectin blockade in COVID-19-related ARDS.
Neri T; Nieri D; Celi A
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1237-L1238. PubMed ID: 32464083
[No Abstract] [Full Text] [Related]
3. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
Bendjelid K; Giraud R; Von Düring S
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
[No Abstract] [Full Text] [Related]
4. Dapsone and doxycycline could be potential treatment modalities for COVID-19.
Farouk A; Salman S
Med Hypotheses; 2020 Jul; 140():109768. PubMed ID: 32339778
[No Abstract] [Full Text] [Related]
5. Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.
Cardinale M; Esnault P; Cotte J; Cungi PJ; Goutorbe P
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):471-472. PubMed ID: 32505755
[No Abstract] [Full Text] [Related]
6. Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
Caocci G; La Nasa G
Ann Hematol; 2020 Jul; 99(7):1675-1676. PubMed ID: 32405693
[No Abstract] [Full Text] [Related]
7. COVID-19-related Acute Respiratory Distress Syndrome: Not So Atypical.
Bos LDJ
Am J Respir Crit Care Med; 2020 Aug; 202(4):622-624. PubMed ID: 32579026
[No Abstract] [Full Text] [Related]
8. Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS.
Turi S; Nardelli P; Landoni G
Ann Card Anaesth; 2020; 23(3):258-259. PubMed ID: 32687078
[No Abstract] [Full Text] [Related]
9. Colchicine may not be effective in COVID-19 infection; it may even be harmful?
Cumhur Cure M; Kucuk A; Cure E
Clin Rheumatol; 2020 Jul; 39(7):2101-2102. PubMed ID: 32394215
[No Abstract] [Full Text] [Related]
10. Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: Mini-review of the literature.
D'Abramo A; Lepore L; Palazzolo C; Barreca F; Liuzzi G; Lalle E; Nicastri E
Int J Infect Dis; 2020 Aug; 97():236-239. PubMed ID: 32565366
[TBL] [Abstract][Full Text] [Related]
11. Risk of COVID-19 disease in the elderly population and physiotherapy.
Özkeskin M; Elibol N; Bakırhan S
Physiotherapy; 2020 Sep; 108():76-77. PubMed ID: 32717618
[No Abstract] [Full Text] [Related]
12. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock.
Wang H; Das S; Wieruszewski PM; Taji J; Bartlett B; Azad N; Chowdhury A; Kolar GJ; Jain N; Subla MR; Khan SA
Chest; 2020 Aug; 158(2):e55-e58. PubMed ID: 32335068
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].
Pan C; Xie JF; Qiu HB; Yang Y
Zhonghua Shao Shang Za Zhi; 2020 May; 36(5):330-333. PubMed ID: 32456368
[TBL] [Abstract][Full Text] [Related]
14. The baby lung and the COVID-19 era.
Gattinoni L; Meissner K; Marini JJ
Intensive Care Med; 2020 Jul; 46(7):1438-1440. PubMed ID: 32451579
[No Abstract] [Full Text] [Related]
15. SARS-CoV-2-induced Acute Respiratory Distress Syndrome: Pulmonary Mechanics and Gas-Exchange Abnormalities.
Barbeta E; Motos A; Torres A; Ceccato A; Ferrer M; Cilloniz C; Bueno L; Badia JR; Castro P; Ferrando C; Andrea R; Castellà M; Fernández J; Soriano A; Mellado R; López-Aladid R; Yang H; Yang M; Fernandez-Barat L; Catalina Palomeque A; Vollmer I; Nicolás JM;
Ann Am Thorac Soc; 2020 Sep; 17(9):1164-1168. PubMed ID: 32579033
[No Abstract] [Full Text] [Related]
16. Management of COVID-19 Respiratory Distress.
Marini JJ; Gattinoni L
JAMA; 2020 Jun; 323(22):2329-2330. PubMed ID: 32329799
[No Abstract] [Full Text] [Related]
17. Management of respiratory failure due to covid-19.
Wilcox SR
BMJ; 2020 May; 369():m1786. PubMed ID: 32366375
[No Abstract] [Full Text] [Related]
18. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.
Soto M; diZerega G; Rodgers KE
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972018. PubMed ID: 33169644
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary embolism and coronavirus disease 2019: persistent pulmonary hypertension?
Cruz-Utrilla A; Calderón-Flores M; Escribano-Subias MP
Kardiol Pol; 2020 Sep; 78(9):937-938. PubMed ID: 32550733
[No Abstract] [Full Text] [Related]
20. Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection.
Faul JL; Kerley CP; Love B; O'Neill E; Cody C; Tormey W; Hutchinson K; Cormican LJ; Burke CM
Ir Med J; 2020 May; 113(5):84. PubMed ID: 32603575
[No Abstract] [Full Text] [Related]
[Next] [New Search]
